Healthy gut microflora and allergy: Factors influencing development of the microbiota

Annals of Medicine

Volumn 31, Issue 4, 1999, Pages 288-292

  Kirjavainen, Pirkka V ^a,c   Gibson, Glenn R ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF READING   (United Kingdom)

^c Dept of Biochem and Food Chemistry ^*  (Finland)

Author keywords

Allergy; Gastrointestinal immunology; Hypersensitivity; Intestinal microflora; Microbial colonization

Indexed keywords

ANTIBIOTIC AGENT; FOOD ADDITIVE; IMMUNOGLOBULIN A; PROBIOTIC AGENT;

ALLERGY; BACTERIAL COLONIZATION; DELIVERY; DEVELOPMENT; ENVIRONMENTAL FACTOR; HELPER CELL; HEREDITY; HUMAN; HYGIENE; IMMUNE SYSTEM; INCUBATOR; INFLAMMATION; INTESTINE FLORA; MICROFLORA; NEWBORN; PRIORITY JOURNAL; REVIEW; SENSITIZATION;

EID: 0032783002     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899908995892     Document Type: Review

References (47)

1. Gibson GR, Macfarlane GT, eds. Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology. Boca Raton, FL: CRC Press; 1995.
2. Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 1986; 31(9 Suppl): 147S-62S.
3. Roberfroid MB, Bornet F, Bourley C, Cummings JH. Colonic microflora: nutrition and health. Nutr Rev 1995; 53: 127-30.
4. Bauer H, Paronetto F, Burns WA, Einheber A. The enhancing effect of the microbial flora on macrophage function and the immune response. A study in germfree mice. J Exp Med 1966; 123: 1013-24.
5. Crabbé P, Bazin H, Eyssen H, Heremans J. The normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the gut. Int Arch Allergy Appl Immunol 1968; 34: 362-75.
6. MacDonald TT, Carter PB. Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. J Immunol 1979; 122: 2624-9.
7. Pulverer G, Ko HL, Roszkowski W, Beuth J, Yassin A, Jeljaszewicz J. Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Int J Med Microbiol 1990; 272: 318-27.
8. Dahlgren UIH, Wold AE, Hanson LA, Midtvedt T. Expression of a dietary protein in E. coli renders it strongly antigenic to gut lymphoid tissue. Immunology 1991; 73: 394-7.
9. Van de Merwe JP, Stegeman JH, Hazenberg MP. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease? Antonie Van Leeuwenhoek 1983; 49: 119-24.
10. Bennet R, Nord CE. Development of the faecal anaerobic microflora after caesarean section and treatment with antibiotics in newborn infants. Infection 1987; 15: 332-6.
11. Adlerberth. Establishment of normal intestinal microflora in the newborn infant. In: Hanson LA, Yolken RH, eds. Probiotics, Other Nutritional Factors, and Intestinal Microflora. Nestlé Nutrition Workshop Series, Vol. 42. Philadelphia, PA: Lippicott-Raven Publishers; 1999: 63-78.
12. Kuhn I, Tullus K, Mollby R. Colonisation and persistence of Escherichia coli phenotypes in the intestine of children aged 0 to 18 months. Infection 1986; 14: 7-12.
13. Rotimi VO, Duerden BI. The development of the bacterial flora in normal neonates. J Med Microbiol 1981; 14: 51-62.
14. Yoshiota M, Fujita K, Sakata H, Murono K, Iseki K. Development of the normal intestinal flora and its clinical significance in infants and children. Bifidobacteria Microflora 1991; 10: 11-7.
15. Mestecky J, Russell MW, Elson CO. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 1999; 44: 2-5.
16. Mevissen-Verhage EAE, Marcelis JH, de Vos MN, Harmsenvan Amerongen WCM, Verhoef J. Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement. J Clin Microbiol 1987; 25: 285-9.
17. Tannock GW, Fuller R, Smith SL, Hall MA. Plasmid profiling of members of the family Enterobacteriaceae, lactobacilli, and bifidobacteria to study the transmission of bacteria from mother to infant. J Clin Microbiol 1990; 28: 1225-8.
18. Bettelheim KA, Lenox-King SMJ. The acquisition of Escerichia coli by newborn babies. Infection 1976; 4: 174-9.
19. Grönlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999; 28: 19-25.
20. Hall MA, Cole CB, Smith SL, Fuller R, Rolles CJ. Factors influencing the presence of faecal lactobacilli in early infancy. Arch Dis Childhood 1990; 65: 185-8.
21. Adlerberth I, Carlsson B, de Man P, Jalil F, Khan SR, Larsson P, et al. Intestinal colonisation with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants. Acta Paediatr Scand 1991; 80: 602-10.
22. Adlerberth I, Jalil F, Carlsson B, Mellander L, Hanson LA, Larsson P. High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol Infect 1998; 121: 587-98.
23. Bennet R, Eriksson M, Nord CE, Tafari N. Transient, asymptomatic colonisation of newborn Ethiopian infants by Salmonella. Infection 1994; 22: 49-50.
24. Fryklund B, Tullus K, Burman LG. Epidemiology of enteric bacteria in neonatal units - influence of procedures and patient variables. J Hosp Infect 1991; 18: 15-21.
25. Stark PL, Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 1982; 15: 189-203.
26. Shroff K, Meslin K, Cebra J. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun 1995; 63: 3904-13.
27. Hanson LÅ, Dahlman-Höglund A, Karlsson M, Lundin S, Dahlgren U, Telemo E. Normal microbial flora of the gut and the immune system. In: Hanson LÅ, Yolken RH, eds. Probiotics, Other Nutritional Factors, and Intestinal Microflora. Nestlé Nutrition Workshop Series, Vol. 42. Philadelphia, PA: Lippicott-Raven Publishers; 1999: 217-28.
28. Gaboriau-Routhiau V, Moreau MC. Gut flora allows recovery of oral tolerance to ovalbumin in mice after transient breakdown mediated by cholera toxin or Escherichia coli heat-labile enterotoxin. Pediatr Res 1996; 39: 625-9.
29. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 1739-45.
30. Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics - a novel approach in the management of food allergy. Allergy (in press).
31. Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon g. Proc Natl Acad Sci USA 1996; 93: 2879-83.
32. Weiner HL, Gonnella PA, Slavin A, Maron R. Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines. Res Immunol 1997; 148: 528-33.
33. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105: 1643-50.
34. Sütas Y, Hurme M, Isolauri E. Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol 1996; 43: 687-9.
35. Sütas Y, Soppi E, Korhonen H, Syväoja EL, Saxelin M, Rokka T, et al. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J Allergy Clin Immunol 1996; 98: 216-24.
36. Moreau MC, Ducluzeau R, Guy-Grand D, Muller MC. Increase in the population of duodenal IgA plasmocytes in axenic mice monoassociated with different living or dead bacterial strains of intestinal origin. Infect Immun 1978; 21: 532-9.
37. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-4.
38. Yasui H, Nagaoka N, Mike A, Hayakawa K, Ohwaki M. Detection of Bifidobacterium strains that induce large quantities of IgA. Microb Ecol Health Dis 1992; 5: 155-62.
39. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-85.
40. Takahashi T, Nakagawa E, Nara T, Yajima T, Kuwata T. Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens. Biosci Biotechnol Biochem 1998; 62: 10-5.
41. Ouwehand AC, Kirjavainen PV, Shortt C, Salminen S. Probiotics: mechanisms and established effects. Int Dairy J 1999; 9: 43-52.
42. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of probiotics. J Nutr 1995; 125: 1401-12.
43. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333-8.
44. Fuller R, Gibson GR. Probiotics and prebiotics: microflora management for improved gut health. Clin Microbiol Infect 1998; 4: 477-80.
45. Gibson GR, Beatty EB, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108: 975-82.
46. Buddington RK, Williams CH, Chen SC, Witherly SA. Dietary supplementation of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 1996; 63: 709-16.
47. Kleessen B, Sykura B, Zunft HJ, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997; 65: 1397-402.